Members
| Location: | Mississauga, Ontario |
|---|---|
| Industry Sector: | Pharma |
| Website: | www.eisai.ca |
| Contact: |
Oliver Technow (info@eisai.ca) 1 905 3617130 |
| Ownership: | Subsidiary - Tokyo Stock Exchange (TSE): 4523 |
| Description: | Eisai Limited is a new Canadian affiliate company of Japanese research-based, human health care (hhc) company, Eisai Co., Ltd., which brings unique and innovative therapies to Canadian patients in such areas as oncology and neurology. They are working with Health Canada on the approval of select products from the Eisai Inc. portfolio to be introduced in the Canadian market. |
| Location: | Toronto, Ontario |
|---|---|
| Industry Sector: | Pharma |
| Website: | www.lilly.ca |
| Contact: |
Michael McDougall (mcdougall_michael@lilly.com) 1 416 694 3221 |
| Ownership: | Subsidiary - : |
| Description: | Lilly develops a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Eli Lilly Canada, headquartered in Toronto, Ontario, employs more than 500 people across the country. |
| Location: | Vancouver, British Columbia |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | www.engeneinc.com |
| Contact: |
Anthony T. Cheung (info@engeneinc.com) 1 604 2214362 |
| Description: | enGene Inc. develops highly flexible nucleotide (DNA and RNAi) delivery technology targeting mucosal tissues to treat numerous prevalent, chronic diseases via the induction or suppression of protein expression levels. The company offers GEMS, gut endocrine-cell modification system, which provides long-term treatment for serious chronic diseases. |
| Location: | Vancouver, British Columbia |
|---|---|
| Industry Sector: | Professional Services and Consulting |
| Website: | www.ey.com |
| Contact: |
Roderick Budd (rod.budd@ca.eyi.com) 1 604 891 8200 |
| Description: | Ernst & Young provide global services in four main areas: Assurance, Tax, Transactions and Advisory. |
| Location: | Vancouver, British Columbia |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | essapharmaceuticals.com |
| Contact: |
1 778 331-0962 |
| Description: | ESSA is developing drugs which selectively block the N-terminus of the androgen receptor, potentially by-passing all the known mechanisms of Castrate-Resistant Prostate Cancer, providing recurrent prostate cancer patients the potential for significant increases in progression-free survival. |
